BL

Brian Leedman

Patrys Limited | Non-Executive Director
Mr Leedman is a biotechnology executive and company director with more than 20 years of experience in corporate strategy, investor relations, and capital markets within the life sciences sector. He is the founder and former director of ResApp Health Ltd, which was acquired by Pfizer Inc. in 2022, and has held board roles across a range of ASX-listed biotechnology companies, including Neuroscientific Biopharmaceuticals, Neurotech International, Alcidion Corporation, Oncosil and others. Mr Leedman is currently a Non-Executive Chairman of Blinklab Ltd and has experience guiding emerging biomedical companies from early research through to clinical development and commercialisation.

Companies and Roles

Company
Title
Tenure
Since
PAB
PAB
Patrys Limited
  • Non-Executive Director
11mthNov 2025
BB1
BB1
BlinkLab Limited
  • Non-Executive Chairman
  • Non-Executive Director
2yrs, 10mthDec 2023

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
BB1
BB1
BlinkLab Limited
10/09/26N/A3,144,1913,000,000N/A
PAB
PAB
Patrys Limited
10/02/262,000,000N/A5,000,000N/A
RSH
RSH
30/05/230620,068N/AN/A
OSL
OSL
11/05/23N/A2,927,9754,500,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
BB1
BB1
BlinkLab Limited
10/09/26
Buy
1,521,000$0.370$562,500Exercise of options
BB1
BB1
BlinkLab Limited
10/09/26
Exercise
2,250,000$0.730$1,642,500Exercise of options
BB1
BB1
BlinkLab Limited
13/07/26
Issued
500,000$0.635$317,500Placement
BB1
BB1
BlinkLab Limited
13/07/26
Issued
83,333$0.650$54,166Placement
PAB
PAB
Patrys Limited
10/02/26
Issued
5,000,000$0.035$175,000Issue of options